CBT

Cabot Corporation 10-K Summary: Fiscal Year Ended September 30, 2003

Business Context and Reporting Period

This Form 10-K covers the fiscal year ended September 30, 2003, for Cabot Corporation, a global manufacturer of specialty chemicals and materials. The Company operates through three reportable segments: the Chemical Business (carbon black, fumed metal oxides, inkjet colorants, aerogels), the Supermetals Business (tantalum, niobium), and the Specialty Fluids Business (cesium formate drilling fluids). Cabot maintains manufacturing facilities in the United States and over 20 other countries. During the fiscal year, the Company initiated significant restructuring in its European operations and purchased the assets of Superior MicroPowders to expand its technology portfolio.

Key Financial Metrics

Segment Performance (Profit Before Taxes):

• Chemical Business: $88 million (down from $101 million in 2002) due to lower margins and restructuring costs.
• Supermetals: $109 million (up from $79 million in 2002) driven by higher volumes and resolved contract disputes.
• Specialty Fluids: $(3) million loss (down from $2 million profit in 2002) due to reduced North Sea drilling activity.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 15% to $1,795 million, driven by higher pricing on long-term carbon black contracts, increased Supermetals volumes, and favorable foreign exchange rates.
• Profit Decline: Net income decreased 25% to $80 million. Income from continuing operations before taxes fell 30% to $94 million, primarily due to $72 million in pre-tax charges for "certain items."
• Restructuring Charges: The Company recorded $51 million in restructuring charges, primarily related to the closure of a carbon black plant in Zierbena, Spain, and workforce reductions in North America and Europe.
• Respirator Liability Reserve: A $20 million reserve was established for existing and future respirator liability claims related to a discontinued business acquired from American Optical Corporation.
• Investment Impairment: A $22 million charge was recorded for the impairment of two investments (Sons of Gwalia and Angus & Ross).
• Acquisition: Purchased Superior MicroPowders for $16 million, expensing $14 million of in-process research and development immediately.

Guidance, Outlook, and Risks

Outlook: Management remains cautious regarding the Chemical Business outlook for 2004 due to downward pricing pressure in non-contracted markets and rising raw material costs. The Supermetals Business expects a decline in profit before taxes to below $79 million due to the expiration of intermediate product contracts, though it anticipates a long-term turnaround in the electronics sector. Specialty Fluids expects improvement driven by new supply arrangements with Statoil.

Key Risks and Contingencies:

• Legal Proceedings: The Company faces antitrust investigations in the U.S. and Europe regarding carbon black pricing. It is also subject to numerous environmental remediation claims (Superfund sites) and personal injury lawsuits related to beryllium and respirator products.
• Environmental Compliance: Potential adoption of EU "BREF Notes" could increase feedstock costs for European carbon black operations. The Company anticipates spending up to $20 million by 2005 to comply with U.S. EPA emissions standards (Carbon Black MACT).
• Customer Concentration: Five major tire/rubber customers, one silicone customer, three capacitor customers, and one microelectronics customer represent a material portion of sales. Goodyear Tire and Rubber Company accounted for 11% of consolidated revenues in 2003.
• Foreign Exchange: Approximately 63% of revenues are derived from outside the U.S., exposing the Company to currency fluctuations.

Investor Verification Checklist

• Restructuring Execution: Verify the timeline and cost savings realization of the European restructuring plan (Zierbena closure) and North American workforce reductions.
• Respirator Liability: Monitor the status of settlement negotiations with the "Payor Group" regarding American Optical respirator claims and the adequacy of the $20 million reserve.
• Antitrust Investigations: Track the progress of U.S. and European antitrust investigations into carbon black pricing and potential litigation outcomes.
• Raw Material Costs: Assess the impact of rising feedstock costs on Chemical Business margins and the ability to pass costs to customers in non-contracted markets.
• Environmental Reserves: Review the $26 million environmental reserve and potential future costs associated with Superfund sites and new regulatory compliance (EPA MACT, EU BREF).
• Supermetals Contract Disputes: Confirm the stability of the resolved tantalum supply contracts and the status of the ongoing dispute with AVX Corporation.